GARATTINI, SILVIO KEN
 Distribuzione geografica
Continente #
NA - Nord America 386
EU - Europa 65
AS - Asia 53
Totale 504
Nazione #
US - Stati Uniti d'America 386
VN - Vietnam 21
IT - Italia 20
CN - Cina 15
BE - Belgio 14
IE - Irlanda 11
SG - Singapore 10
DE - Germania 7
IN - India 5
UA - Ucraina 4
RU - Federazione Russa 3
GB - Regno Unito 2
IR - Iran 2
NL - Olanda 2
CZ - Repubblica Ceca 1
SE - Svezia 1
Totale 504
Città #
Ann Arbor 57
Chandler 54
Ashburn 35
Fairfield 26
Dong Ket 21
Seattle 20
Wilmington 17
Houston 16
Woodbridge 16
Brussels 14
New York 12
Princeton 11
Beijing 9
Dublin 9
Singapore 9
Cambridge 8
Augusta 4
Jacksonville 4
San Giorgio di Nogaro 4
Caserta 3
Dearborn 3
San Diego 3
Boardman 2
Des Moines 2
Jinan 2
Leawood 2
Los Angeles 2
Norwalk 2
Sagrado 2
Trieste 2
Amsterdam 1
Ardabil 1
Brno 1
Dallas 1
Hyderabad 1
Langfang 1
Nanchang 1
Nantong 1
Ogden 1
Phoenix 1
Redwood City 1
San Francisco 1
Shenzhen 1
Udine 1
Venezia 1
Washington 1
Totale 387
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 118
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 84
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 79
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 75
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer 36
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 34
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer 32
HER2–CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients’ Survival in HER2-Positive Metastatic Gastric Adenocarcinoma 24
What to do in an oncology department to face the new COVID-19 era challenges? 22
Systemic Treatments for Advanced Small Bowel Adenocarcinoma: A Systematic Review 15
State-of-the-art of monoclonal antibodies for the treatment of gastric cancer 12
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 11
Totale 542
Categoria #
all - tutte 2.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202089 0 5 1 4 4 5 5 4 21 21 13 6
2020/2021149 8 18 25 14 11 1 6 12 3 6 17 28
2021/2022105 5 8 0 1 3 1 7 6 2 22 38 12
2022/2023115 13 20 5 11 14 25 0 5 13 2 4 3
2023/202473 4 4 3 4 12 25 0 1 3 2 9 6
2024/202511 10 1 0 0 0 0 0 0 0 0 0 0
Totale 542